MENU
EXEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Exelixis (EXEL) Earnings Date & Reports
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
EXEL is expected to report earnings to fall 2.48% to 88 cents per share on November 03
Q3'26
Est.
$0.89
Q2'26
Beat
by $0.07
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.17
Q3'25
Beat
by $0.09
The last earnings report on August 05 showed earnings per share of 91 cents, beating the estimate of 83 cents. With 592.81K shares outstanding, the current market capitalization sits at 14.46B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small molecule therapies for the treatment of cancer
Industry Biotechnology
Industry
Biotechnology
Address
1851 Harbor Bay Parkway
Phone
+1 650 837-7000
Employees
4600
Web
https://www.exelixis.com